A naukri.com initiative
Bioengineer
2d
360
Image Credit: Bioengineer
Queen Mary University Unveils Innovative Spinout in Regenerative Medicine Aimed at Joint Repair and Arthritis Prevention
- Queen Mary University of London introduces a pioneering approach in regenerative medicine to treat osteochondral defects and prevent arthritis.
- The method utilizes an Agrin-derived peptide that enhances natural repair mechanisms and inhibits cartilage breakdown.
- Unlike traditional therapies, this non-invasive treatment reduces complexity, making it more accessible and efficient.
- Promptly addressing osteochondral defects may potentially prevent the progression to osteoarthritis, benefiting millions afflicted globally.
- This innovation offers a cost-effective alternative to current cartilage repair modalities, easing the burden on healthcare systems.
- Researchers identified a correlation between Agrin levels and osteoarthritis symptoms, paving the way for future therapeutic applications.
- The commercial venture ReFleks aims to transition the treatment into clinical use, with a focus on real-world testing and eventual product rollout.
- The simplified administration process of this treatment allows for accelerated recovery, appealing to athletes seeking quick rehabilitation.
- By repairing cartilage effectively, this treatment can enhance the quality of life for individuals prone to joint injuries and potential osteoarthritis.
- The market for cartilage repair is expanding, with ReFleks positioned to capture a significant share by prioritizing patient outcomes and safety.
Read Full Article
21 Likes
For uninterrupted reading, download the app